Loading...
XAMS
CRBN
Market cap1.25bUSD
Dec 04, Last price  
18.45EUR
1D
-2.17%
1Q
5.49%
Jan 2017
-27.45%
Name

Corbion NV

Chart & Performance

D1W1MN
XAMS:CRBN chart
P/E
5.58
P/S
0.83
EPS
3.31
Div Yield, %
7.15%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
5.70%
Revenues
1.29b
-10.78%
2,391,600,0002,421,400,0002,485,600,0002,599,300,0002,555,900,0002,990,100,0003,112,600,000753,700,000743,600,000770,100,000918,300,000911,300,000891,700,000897,200,000976,400,000986,500,0001,070,800,0001,457,900,0001,443,800,0001,288,100,000
Net income
192m
+163.65%
423,400,000104,700,000202,800,00090,000,00086,800,00099,300,000-174,300,000-63,700,0002,400,000-20,700,00080,200,000103,600,00084,600,00054,300,00025,800,00073,100,00078,300,00090,000,00072,900,000192,200,000
CFO
184m
+11.31%
833,000,000177,800,000138,800,00098,500,000277,200,000188,600,000148,000,000197,400,0009,900,00066,800,000110,300,000122,600,000117,700,00099,500,000115,700,000113,400,00026,700,00053,200,000165,400,000184,100,000
Dividend
May 16, 20250 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.
IPO date
Jan 04, 1999
Employees
2,601
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT